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Summary
Objective: Disturbances in proteoglycan metabolism of hyaline cartilage play an essential role in the pathology of degenerative joint disease.
We investigated the relation between transcript expression, protein synthesis and the ultrastructural localization of the matrix-organizing
proteoglycans decorin and biglycan within intra- and extracellular compartments of late-stage osteoarthritic human articular cartilage.
Methods: Human cartilage samples of a macroscopically intact area, the adjoining area and an area of the main defect from knee joints of
10 patients with late stage osteoarthritis were investigated. In situ hybridization and immunogold histochemistry were carried out separately
and in combination at the light and electron microscopic level.
Results: Ultrastructurally, three main chondrocyte types were identified. The highest levels of mRNA of decorin and biglycan were produced
by elongated secretory type 2 cells, already known to synthesize type I collagen. Cells with high levels of mRNA also translated the
corresponding proteins to be found in the extracellular compartment. The highest production rate of decorin and biglycan was seen in the
tissue area adjoining the main defect.
Conclusion: The results indicate that at late stages of osteoarthritis the levels of transcription and translation for decorin and biglycan
are up-regulated, probably in an effort to compensate for the general proteoglycan loss, characteristic of this disease stage.
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397067.Introduction
The resilience, integrity and function of articular cartilage is
guaranteed by the two major components of its extra-
cellular matrix, collagens and proteoglycans. Normal adult
articular cartilage contains type II, IX, and XI collagen. Type
II, IX and XI collagen are organized into heterotypic matrix
fibrils where collagen XI nucleates self-assembly and limits
lateral growth of the mainly type II collagen-containing
fibrils. Type IX collagen strongly increases the efficiency of
fibril formation and may allow interactions with other extra-
cellular matrix components1. Collagen fibrils are also
known to interact with matrix proteoglycans like aggrecan2,
decorin and biglycan3.
According to the nature of their core proteins, proteo-
glycans are divided into large, hyaluronan-binding proteo-
glycans like aggrecan and small proteoglycans such
as decorin, biglycan, epiphycan and fibromodulin4. The
proteins of the latter group are characterized by core654proteins composed of leucine-rich repeat structures
enabling these molecules to interact with collagens, matrix
glycoproteins and cell membrane components4. Decorin
and biglycan represent a structurally and genetically well-
defined subfamily among these molecules. In addition, they
are both linked to one or two chondroitin/dermatan sulfate
chains which may be resonsible for further interactions. It
had been suggested, for example, that the orthogonal
positioning of a small proteoglycan induces the proper
spacing of the collagen fibrils during axial growth or lateral
fusion by the formation of glycosaminoglycan chains
oriented in an antiparallel manner when the core proteins
are bound to adjacent fibrils5. However, decorin and bi-
glycan may fulfill different functions in extracellular matrix
assembly since they differ in both ultrastructural distribution
within normal cartilage3 and binding qualities6.
Decorin is involved in the regulation of important biologi-
cal functions like matrix organization, cell adhesion, migra-
tion and proliferation7–9. Biglycan is found in many
connective tissues, such as skin, bones and blood ves-
sels10,11. Within the hyaline cartilage tissue, biglycan is
localized mainly pericellularly while decorin is found in the
interterritorial matrix3. Because of its specific localization
in the pericellular space as well as on the chondrocyte
cell surface, biglycan may have important functions in
modulating morphogenesis and differentiation12.
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TISSUE SAMPLES
Adult articular cartilage was obtained from the medial
femoral condyles of 10 knee joints from patients (ages
52–77 years) undergoing therapeutic Pridie drilling duringosteotomy for OA due to axis deviation. All patients suffered
from late stage OA and met the American College of
Rheumatology classification criteria for OA of the knee20.
All patients gave their written informed consent according
to the Ethics Regulations of the Medical Faculty of the
Georg-August University Goettingen. Specimens were
taken from the main defective area of maximal load, an
area directly adjoining the defect and a macroscopically
undamaged region located towards the edge of the
condyles.TISSUE EMBEDDING AND SECTIONING
For light microscopy, specimens were embedded in
paraffin according to standard procedures21. For electron
microscopy, they were cut into 1×1 mm2 samples, fixed
immediately for 30 min in 4% paraformaldehyde and 0.5%
glutaraldehyde in phosphate-buffered saline, pH 7.4 (PBS),
dehydrated in up to 70% ethanol and embedded in the
hydrophilic resin LR-Gold® (London Resin Company,
Reading, UK)21. Paraffin sections (5–7 m) for Alcian blue
staining, semithin (1 m) sections for the histopathological
grading and ultrathin (70 nm) sections for the ultrastructural
analysis were cut. The sectioning plane was determined
and, if necessary, re-embedding guaranteed a longitudinal
orientation of the specimens.Fig. 1. (a) Radiograph of a patient with grade IV OA. Areas from which the cartilage samples were taken are marked (black arrow=main
defect, open triangle=adjoining area and black-on-white arrow=macroscopically intact), bar=2 cm. (b) Alcian blue staining of a cartilage
sample from the macroscopically intact area; note that chondrocytes are organized in clusters (black arrow), bar=50 m. (c) Light
microscopic in situ hybridization in a sample similar to (b), intracellular staining for biglycan mRNA (black arrows), bar=50 m, inset: higher
magnification of two cell clusters.ANTIBODIES AND GOLD LABELING
Anti-DIG-antibody (sheep-IgG), non-stabilized and free
of additive solutions, was purchased from Quartett, Berlin,Decorin and biglycan are both involved in the patho-
physiology of osteoarthritis (OA). During the disease pro-
cess cell cluster formation, collagen fiber fibrillation and
surface splits occur within the hyaline cartilage tissue,
eventually leading to the total destruction of the articular
surface13. In addition to mechanical and cytokine influ-
ences, an imbalance between the synthesis and degrada-
tion of matrix components14, mainly a loss of aggrecan and
collagen type II15,16, are known to be responsible for OA. At
the light microscopic level, reduced amounts of the small
proteoglycans decorin and biglycan have been described
for this disease17, as well as higher levels of the corre-
sponding mRNAs when compared with physiological
cartilage18. Nothing is known about their occurrence in OA
at the ultrastructural level. We correlated the appearance of
protein and mRNA of decorin and biglycan with different
chondrocyte cell types16,19 of late stage osteoarthritic car-
tilage from knee joints of ten patients. Additionally, we
performed electron microscopic in situ hybridization simul-
taneously with immunogold histochemistry on the same
tissue sections to determine whether the transcriptional
activity of a certain chondrocyte type is paralleled by
protein synthesis.
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anti-sheep antibody from Roche Diagnostics, Heidelberg,
Germany. The production and characterization of the rabbit
antisera against decorin core protein prepared from human
fibroblasts22 and against an antigen consisting of amino
acids 113–126 of the secreted form of biglycan23 has been
described previously. The antibodies were affinity purified
before gold labeling. Gold particles with a diameter of
16 nm were prepared for the labeling of the anti-DIG
antibody and 8 nm gold particles for the anti-decorin and
anti-biglycan antibodies. Briefly, the minimal protecting
amount of protein was determined by a dilution series and
the freshly reduced colloidal gold particles were mixed with
the appropriate amount of antibody. To separate coupled
from uncoupled gold particles, several centrifugation steps
followed21.ELECTRON MICROSCOPIC IMMUNOGOLD HISTOCHEMISTRY
Ultrathin tissue sections on nickel grids were incubated
with 1% BSA in PBS. Following chondroitinase ABC
(Sigma, Deisenhofen, Germany) treatment, grids were
incubated with the 8 nm gold labeled anti-decorin or anti-
biglycan antibodies diluted 1:20 in PBS for 16 h at 4°C. The
grids were thoroughly rinsed and contrasted with uranyl
acetate and lead citrate (each for 10 min). Subsequently,
grids were examined and micrographs taken up to a
magnification of ×50,000 with a Zeiss EM109. For controls,
tissue sections were incubated with pure colloidal gold
solution in order to exclude binding of uncoupled gold
particles to tissue structures. To exclude non-specific IgG
binding, the reaction was performed with gold-coupled
goat-anti-rabbit IgG and serum of non-immunized
animals21. All controls were negative.PROBE PREPARATION
The decorin- and biglycan-specific RNA probes were
cloned in a pGEM-vector (Promega, Southampton, U.K.).
Fragments of decorin contained a nucleotide sequence of
273 bp for decorin24 and a 198 bp sequence for the bigly-
can25 core protein. In vitro transcription of non-radioactive
sense- and antisense-RNAs with digoxigenin labeling
(Roche Diagnostics, Heidelberg, Germany) was performed
using the T3- and T7- polymerases (MBI Fermentas, St
Leon-Rot, Germany). Following extraction of the probes
with phenol-chloroform these were precipitated with
absolute ethanol and dissolved in DEPC-H O.2IN SITU HYBRIDIZATION
For the hybridization reaction, an incubation solu-
tion consisting of 50% formamide, 5×SSC, 0.1 mg/l
yeast-tRNA and 10 ng/l probe was prepared. Probe
concentration for decorin and biglycan was 100 ng
digoxigenin-labeled antisense probe in 20 l solution per
section for ultrastructural and 20 ng labeled probe per
50 m solution for light microscopic hybridizations. The
reactions were carried out at 50°C for 20 h. Post-
hybridization treatment consisted of washes with 1×SSC
(2×15 min at 50°C), 1×SSC (2×15min at 60°C), 0.1×SSC
(3×15min at 60°C). For electron microscopy, grids were
treated with PBS for 15 min and then incubated with a 1:50
dilution of the anti-DIG 16 nm gold-labeled antibody in PBS
for 1 h at room temperature16. For light microscopy, sec-
tions were treated with anti-DIG antibodies diluted 1:100 in
PBS for 3 h and afterwards the secondary phosphatase-
conjugated swine-anti-sheep IgG was applied. Color reac-
tions were performed with NBT/BICP substrate. Controls
were incubated with an equivalently labeled amount of
sense-RNA in the same way as described for the antisense
probe.COMBINATION OF ELECTRON MICROSCOPIC IMMUNOGOLD
HISTOCHEMISTRY AND IN SITU HYBRIDIZATION
For the double labeling procedure, 8 nm gold particles
were used for the immunohistochemisty, and 16 nm parti-
cles to detect the hybridization product. Immunogold histo-
chemistry was carried out as described above and, after a
thorough rinse with PBS, the tissue sections were stored in
buffer for 2 h at room temperature. The in situ hybridization
reaction followed as described above. The controls were
the same as for the single reactions and all proved to be
negative.Table I
Data of patients with advanced OA of the knee joint
Patient Sex Age Height
(cm)
Weight
(kg)
Pain Swelling OA-grade
1 Female 52 161 80 Rest Yes III–IV
2 Male 76 176 87 Load Yes III
3 Male 56 173 80 Load Yes IV
4 Female 77 160 84 Rest No IV
5 Female 70 165 85 Load No III–IV
6 Female 74 165 65 Load Yes II–III
7 Male 63 183 89 Rest Yes IV
8 Female 76 162 73 Rest No IV
9 Male 71 171 73 Rest No III
10 Male 56 182 93 Load Yes II–III
67.1 169.8 80.9 ∼III–IVSTATISTICAL ANALYSIS
Micrographs of the different cell types or tissue areas of
specimens from each patient, at identical magnifications,
were pooled and randomly counted for gold particle con-
tents, N=10. Mean values (with S.E.M. ranging from 1–11
gold particles) of the numbers of gold particles per cell,
after electron microscopic in situ hybridization for decorin
and biglycan with antisense probes, were analysed. Signifi-
cant differences in the number of gold particles were noted
Osteoarthritis and Cartilage Vol. 9, No. 7 657for P-values (P≤0.001) using the Wilcoxon–Mann–Whitney
test for unpaired samples for patients nos. 1, 4 and 9.ResultsPATIENT DATA
The specimens from the patients macroscopically
exhibited advanced osteoarthritic joint surfaces [Fig. 1(a)]
which could be characterized pathohistologically as OA
grade II–III, III–IV and grade IV26. All patients suffered from
load or even rest-pain of the knees and temporary or
permanent joint swelling. No significant correlation
between sex, age, weight, pathohistological grade of OA
and the corresponding clinical condition could be found
(Table I).LIGHT MICROSCOPIC HISTOLOGY
The macroscopically intact cartilage of the patients with
late stages of OA revealed clusters of chondrocytes in a
homogeneously stained extracellular matrix [Fig. 1(b)].
With decreasing distance to the main defective areas of
maximal load, reduced Alcian blue staining of the extra-
cellular matrix, indicating a proteoglycan loss, and increas-
ing variability of the cellular shape were found. The tissue
near the main defective areas exhibited elongated cells in a
fibrillated matrix resembling scar tissue16. The main defec-
tive area showed cells of varying degrees of degenerative
phenotypes surrounded by a maximally fibrillated matrix, a
destroyed tidemark with denuded subchondral bone and
sprouting blood vessels.ELECTRON MICROSCOPIC HISTOLOGY
Ultrastructurally, macroscopically undamaged areas
exhibited chondrocytes of normal phenotype with sparse,
finely structured endoplasmic reticulum [type 1 cells;
Fig. 2(a)]. The cells were surrounded by a homogeneous
extracellular matrix with collagen fibers next to more
globular structures representing proteoglycans. The adjoin-
ing areas revealed a more fibrillated extracellular matrix
surrounding cells of irregular, elongated shape [Fig. 2(b)]
with great amounts of enlarged rough endoplasmic
reticulum which resembled cells described as type 2
secretory cells16,19. The specimens of the main defective
areas showed type 3 cells in different stages of degener-
ation with pyknotic nuclei and a dense, occasionally partly
dissolved, cytoplasm [Fig. 2(c)]. The extracellular environ-
ment presented maximal fibrillation and degraded collagen
fibers as disseminated dense deposits (Table II).Fig. 2. Electron micrographs of the three chondrocyte types: type 1
cell (a), type 2 cell (b) and type 3 cell (c), N=nucleus, black
arrows=endoplasmic reticulum. Bars=0.7 m.IN SITU HYBRIDIZATION FOR DECORIN AND BIGLYCAN mRNA
Light microscopic in situ hybridization of the cartilage
tissues exclusively revealed intracellular staining for both
proteoglycans in all samples investigated. A specimen from
a macroscopically intact area is shown for biglycan mRNA
staining of the cytoplasm of chondrocytes arranged in
clusters [Fig. 1(c)].
To render the differentiation of the cell types seen at the
ultrastructural level possible and for a quantification of the
results27, electron microscopic in situ hybridization was
performed. Staining for decorin was found in all three celltypes identified. The staining intensity was highest in the
elongated type 2 cells. All specimens investigated showed
a 30–50% higher amount of decorin mRNA in type 2 cells
as compared with type 1 and type 3 cells (Fig. 3). When the
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Fig. 3. Mean values of the decorin in situ hybridizations are shown for the three cell types depicted in Fig. 2. Type 1 cells, ;
type 2 cells, ; type 3 cells, .0
250
Number of patient
N
u
m
be
r 
of
 g
ol
d 
pa
rt
ic
le
s 
pe
r 
ce
ll 200
150
100
50
1 2 3 4 5 6 7 8 9 10
Fig. 4. Mean values of the decorin in situ hybridizations are shown for the three tissue areas depicted in Fig. 1(a). Macroscopically intact
area, ; adjoining area, ; area of maximal load, .Table II
Overall ultrastructural appearance of the cartilage samples
Macroscopically intact areas Adjoining areas Areas of maximal load
Cells Normal, clonal type 1 cells* Secretory type 2 cells with high amounts of
enlarged rough endoplasmic reticulum
Degenerative type 3 cells
Matrix Finely structured collagen fibres and globular
structures representing proteoglycans
Enlarged but still mainly organized collagen
fibres
Dense deposits of unorganized
collagen fibres
*According to a recently published classification19.
Osteoarthritis and Cartilage Vol. 9, No. 7 659three different tissue samples of each patient were
analysed, overall staining intensity was highest for the area
adjoining the main defect. It was lowest in the area of the
main defect itself and intermediate in the macroscopically
intact samples from the edges of the condyles (Fig. 4). The
staining was localized next to the rough endoplasmic
reticulum in the cytoplasm of the chondrocytes of the
varying cell types [Fig. 5(a), (c)]. Control hybridization with
sense probes for decorin were negative [Fig. 5(e)]. Staining
for biglycan mRNA was also found in all cell types investi-
gated and again was highest in the type 2 cells and lowest
in type 3 cells (Fig. 6). Comparing the three tissue samples
from each patient, biglycan mRNA staining intensity was
also highest in the area adjoining the area of the maindefect (Fig. 7). Staining for biglycan mRNA was also
localized adjacent to the rough endoplasmic reticulum in
the cytoplasm of all cell types investigated [Fig. 5(b), (d)].
Control hybridizations for biglycan were negative as well
[Fig. 5(f)].Fig. 5. Ultrastructural in situ hybridization on cartilage tissues for decorin (a), (c), (e) and biglycan (b), (d), (f) are shown. Decorin (a) and
biglycan (b) mRNA adjacent to the rough endoplasmic reticulum (black arrows) in a type 2 cell, bars=0.3 m. Higher magnification of rough
endoplasmic reticulum within a type 2 cell with staining for decorin (c) and biglycan (d) mRNA, bars=0.15 m. Control hybridization with a
sense probe for decorin (e) and biglycan (f), no staining is seen in type 2 cells, N=nucleus, bars=0.3 m.PROTEIN AND MRNA DOUBLE LABELING FOR DECORIN AND
BIGLYCAN
Most of the decorin and biglycan was found in the
extracellular matrix of the cartilage tissues. As already
shown for normal human articular cartilage3 and also in the
tissue samples of late stages of OA investigated here,
660 H. C. Bock et al.: The small proteoglycans decorin and biglycan0
250
Number of patient
N
u
m
be
r 
of
 g
ol
d 
pa
rt
ic
le
s 
pe
r 
ce
ll 200
150
100
50
1 2 3 4 5 6 7 8 9 10
Fig. 6. Mean values of the biglycan in situ hybridizations are shown for the three cell types depicted in Fig. 2. Type 1 cells, ;
type 2 cells, ; type 3 cells, .0
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Fig. 7. Mean values of the biglycan in situ hybridizations are shown for the three tissue areas depicted in Fig. 1(a). Macroscopically intact
area, ; adjoining area, ; area of maximal load, .decorin was located in the interterritorial matrix [Fig. 8(a)],
while biglycan, in contrast to the normal cartilage tissue3,
was not only seen in the pericellular, but also the inter-
territorial space. Staining of both proteoglycans was
associated with the collagen fibers. Increased mRNA and
intracellular protein levels were found in secretory type 2
cells when the surrounding extracellular matrix exhibited
weak staining for the proteoglycan. In contrast, secretory
cells surrounded by a matrix heavily stained for either
proteoglycan showed a lower staining intensity for its
mRNA and corresponding protein within the cytoplasm(data not shown). The double labeling approach allowed
determination of whether the transcripts detected for both
small proteoglycans are also translated into decorin or
biglycan at the same time. For both proteoglycans, mRNA
and corresponding protein were localized in the same
cells. While staining for the protein (represented in the
micrograph by the small gold particles) was found in the
lumen of the rough endoplasmic reticulum, the cor-
responding mRNA (represented by large gold particles)
was located at the border of the reticulum [Fig. 8(b) and
inset, (c)].
Osteoarthritis and Cartilage Vol. 9, No. 7 661Fig. 8. (a) Immunogold histochemistry for biglycan in the pericel-
lular matrix (black arrow) near a type 2 cell and in the surrounding
interterritorial matrix (open arrow). (b) Immunogold histochemistry
for decorin in the interterritorial matrix (black arrows) near a type 2
cell. Double labeling for decorin (c) and biglycan (d) protein and
their corresponding mRNA, black arrows=small gold particles
represent the protein in the lumen of the rough endoplasmic
reticulum and large gold particles represent the corresponding
mRNA at the border of the reticulum. Bars=0.25 m. In the inset:
*=small gold particles for decorin and fine black arrows=large gold
particles for decorin mRNA, bar=0.13 m.Discussion
Artificially induced full thickness defects in animal
models render definition of reproducible pathohistological
changes in OA possible28. The osteoarthritic cartilage tis-
sues of patients investigated here exhibit signs of de- and
regeneration intimately intermingled. As multifactorial con-
ditions with a complex pathogenesis and without a simple
linear progression lead to OA12–15, a clear histological
delineation of degenerative and regenerative changes is
difficult29. Nevertheless, our tissue samples were graded
histopathologically with reference to a well established
grading system26. At the ultrastructural level we identified
three major chondrocyte types, already described pre-
viously19. These are normal, clonal type 1 cells, elongated
secretory type 2 cells and degenerative type 3 cells. We did
not differentiate between secretory type 2a and type 2b
cells19, which would have been difficult to achieve with the
embedding technique we had to apply for the hybridization
protocol.
In the present study we investigated the expression and
synthesis of the small proteoglycans decorin and biglycan
in human knee joint cartilage of patients suffering from
late-stage OA. By applying electron microscopic immuno-
gold histochemistry and in situ hybridization, the quantifi-
cation of the cellular expression of decorin and biglycan
mRNA in the three ultrastructurally well defined chondro-
cyte types of the cartilage tissues was possible. In artifi-
cially induced OA in dogs, mRNA levels of biglycan,
detected by Northern blot analyses, were higher than those
of decorin30. We also detected higher biglycan than decorin
levels in our human samples. Unfortunately, we cannot
compare the results of decorin and biglycan hybridizations
directly. The number of gold particles does not directly
represent the amount of mRNA, because the two probes
differ in length and one cannot assume a similar hybridiz-
ation rate. The larger probe might form more stable hybrids,
whereas the shorter probe statistically might have a greater
probability of labeling the transcript. However, the immuno-
gold method is a tool with which a correlation between the
number of gold particles and the mRNA concentration can
be established27.
Proteoglycans are known to be involved in the patho-
physiology of OA12,13 and chondrocytes of osteoarthritic
cartilage produce high concentrations of collagenolytic and
proteoglycanolytic enzymes14,31. The amounts of decorin
and biglycan protein have been found by radioimmuno-
assays to be reduced in the diseased tissue when com-
pared to physiological cartilage in one study17, while, by
quantitative PCR and Western blotting, another study
found the proteins and corresponding mRNAs to be
up-regulated in OA18. For the patients investigated here,
we found the decorin and biglycan expression to be highest
in secretory type 2 chondrocytes, cells that are indicative of
a long disease process accompanied by efforts of regen-
eration, and not as high in the remaining normal chondro-
cytes of type 1. As anticipated, the degenerative type 3
cells exhibited the lowest mRNA amounts (Figs 3 and 6).
This indicates that in the face of the general proteoglycan
loss during the disease process, an active secretory cell
type, the elongated chondrocyte type 2, occurs, which
attempts to re-establish the degraded matrix. We can
demonstrate here that these cells produce high amounts of
decorin and biglycan mRNA, which are also translated into
the corresponding proteins. We cannot state whether these
are actually secreted into the matrix. It is still intriguing to
speculate that high amounts of decorin and biglycan in
662 H. C. Bock et al.: The small proteoglycans decorin and biglycanthe extracellular matrix might be beneficial for the matrix
integrity, possibly counteracting the disease process. In
samples from the differing areas of cartilage from the same
patient (main defect, adjoining areas and macroscopically
intact areas), the area adjoining the main defect was
the one most active. Here, transcription for decorin and
biglycan was highest, followed by the macroscopically
intact area and then the area of the main defect (Figs 4 and
7). An increased amount of mRNA does not automatically
represent an amplified synthesis of the corresponding
protein. By combining immunohistochemistry and in situ
hybridization on the same ultrathin tissue section, we can
now demonstrate that the higher expression of decorin and
biglycan mRNA is paralleled by an increased production of
the corresponding protein. We also found that the intra-
cellular message level exhibits an inverse relationship to
the proteoglycan staining of the extracellular matrix. This
might indicate that a low proteoglycan amount in the matrix
is a trigger for an increased intracellular production of the
corresponding mRNA and, in this respect, also points
towards a compensatory effort to rebuild the proteoglycan
content of the extracellular matrix.
The immunohistochemical localization of decorin in the
extracellular matrix of late stage osteoarthritic cartilage
resembled a pattern already described for physiological
articular cartilage of the knee joint3. Decorin was found in
the interterritorial matrix on collagen fibers. In contrast to
the normal in vivo situation, in late-stage osteoarthritic
cartilage biglycan had also accumulated in the inter-
territorial matrix on collagen fibers. In OA, atypical colla-
gens like collagen type I and type III are expressed15,32.
Interactions of biglycan with collagen type I have been
described in vitro6. It is known that the amounts of collagen
type II decrease in OA33. We have demonstrated pre-
viously that the secretory type 2 cells of human late-stage
osteoarthritic cartilage produce collagen type I mRNA and
not collagen type II mRNA16. One might assume that the
collagen fibers seen in our patients are composed of type I
rather than type II. Therefore, biglycan might be involved in
the regulation of collagen type I organization in late stages
of OA.
In summary, these results demonstrate an increased
decorin and biglycan mRNA transcription rate, especially in
secretory type 2 cells of the cartilage areas adjoining
the main defect. Their up-regulation might reflect an effort
to compensate for the general loss of proteoglycans and
an involvement in the regulation of the newly occurring
matrix components such as collagen type I in late stages
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